搜尋





搜尋





Serina Therapeutics Inc

SER

添加自選

2.000USD

+0.030+1.47%

收盤 07-31 16:00（美東）報價延遲15分鐘

30.00M總市值

虧損本益比TTM

Serina Therapeutics Inc

2.000

+0.030+1.47%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

SER 利潤表

您可以在這裡找到Serina Therapeutics Inc的年度或季度收入報告，以深入了解Serina Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

營業總收入

----

--0.00

-100.00%0.00

154.90%130.00K

-100.00%0.00

----

-79.10%14.00K

466.67%51.00K

-50.00%5.00K

600.00%56.00K

644.44%67.00K

-25.00%9.00K

100.00%10.00K

-70.37%8.00K

-62.50%9.00K

-67.57%12.00K

-91.07%5.00K

-82.91%27.00K

-65.22%24.00K

-17.78%37.00K

-37.08%56.00K

-71.22%158.00K

-83.21%69.00K

-88.16%45.00K

-77.06%89.00K

75.40%549.00K

8.16%411.00K

-18.10%380.00K

62.34%388.00K

-31.66%313.00K

0.80%380.00K

53.64%464.00K

-10.49%239.00K

--458.00K

--377.00K

--302.00K

--267.00K

營業收入

----

--0.00

-100.00%0.00

154.90%130.00K

-100.00%0.00

----

-79.10%14.00K

466.67%51.00K

-50.00%5.00K

600.00%56.00K

644.44%67.00K

-25.00%9.00K

100.00%10.00K

-70.37%8.00K

-62.50%9.00K

-67.57%12.00K

-91.07%5.00K

-82.91%27.00K

-65.22%24.00K

-17.78%37.00K

-37.08%56.00K

-71.22%158.00K

-83.21%69.00K

-88.16%45.00K

-77.06%89.00K

75.40%549.00K

8.16%411.00K

-18.10%380.00K

62.34%388.00K

-31.66%313.00K

0.80%380.00K

53.64%464.00K

-10.49%239.00K

--458.00K

--377.00K

--302.00K

--267.00K

主營業務成本

----

0.00%1.00K

560.00%33.00K

-16.67%5.00K

0.00%1.00K

150.00%5.00K

-53.85%6.00K

-66.67%1.00K

-80.00%1.00K

-88.24%2.00K

333.33%13.00K

200.00%3.00K

-93.67%5.00K

-65.31%17.00K

-94.34%3.00K

-98.41%1.00K

-56.11%79.00K

1325.00%49.00K

-32.91%53.00K

-42.20%63.00K

233.33%180.00K

-107.55%-4.00K

1480.00%79.00K

94.64%109.00K

--54.00K

--53.00K

--5.00K

--56.00K

營業費用

7.20%6.28M

11.86%6.21M

20.02%6.39M

45.39%5.70M

151.85%5.86M

53.46%5.55M

119.81%5.33M

106.70%3.92M

7.29%2.33M

102.01%3.62M

55.42%2.42M

18.22%1.90M

5.40%2.17M

-5.49%1.79M

-8.19%1.56M

-28.50%1.60M

-12.43%2.06M

-23.78%1.89M

-31.14%1.70M

-7.09%2.24M

-24.15%2.35M

-23.89%2.48M

-33.17%2.47M

-36.87%2.41M

-11.77%3.10M

-11.06%3.27M

42.91%3.69M

47.11%3.82M

17.39%3.51M

82.09%3.67M

11.92%2.58M

9.99%2.60M

-4.66%2.99M

--2.02M

--2.31M

--2.36M

--3.14M

研發費用

8.40%3.20M

43.81%3.40M

51.18%3.65M

101.92%3.15M

167.30%2.95M

1487.25%2.37M

1205.41%2.42M

1119.53%1.56M

682.98%1.10M

-14.86%149.00K

43.41%185.00K

-43.36%128.00K

-61.16%141.00K

-48.98%175.00K

-46.91%129.00K

-49.55%226.00K

24.74%363.00K

-60.62%343.00K

-60.81%243.00K

-50.33%448.00K

-75.51%291.00K

-40.71%871.00K

-52.56%620.00K

-40.26%902.00K

-0.92%1.19M

-3.55%1.47M

8.11%1.31M

18.25%1.51M

-19.20%1.20M

20.21%1.52M

-15.04%1.21M

12.12%1.28M

-3.89%1.48M

--1.27M

--1.42M

--1.14M

--1.54M

折舊攤銷及損耗

5.88%18.00K

-57.14%24.00K

-71.43%16.00K

-71.93%16.00K

-32.00%17.00K

69.70%56.00K

78.13%57.00K

-24.24%25.00K

0.00%33.00K

-3.03%32.00K

0.00%33.00K

3.13%33.00K

-82.35%33.00K

-87.31%33.00K

-92.96%33.00K

-91.35%32.00K

-49.18%187.00K

-29.16%260.00K

144.27%469.00K

137.18%370.00K

142.11%368.00K

146.31%367.00K

28.00%192.00K

6.85%156.00K

29.91%152.00K

22.13%149.00K

20.00%150.00K

--146.00K

-52.44%117.00K

-44.04%122.00K

--125.00K

----

--246.00K

--218.00K

其他營業費用

----

--14.00K

----

營業利潤

-7.20%-6.28M

-11.86%-6.21M

-20.33%-6.39M

-43.95%-5.57M

-152.39%-5.86M

-55.87%-5.55M

-125.47%-5.31M

-104.98%-3.87M

-7.55%-2.32M

-99.78%-3.56M

-52.00%-2.36M

-18.54%-1.89M

-5.17%-2.16M

4.55%-1.78M

7.41%-1.55M

27.85%-1.59M

10.51%-2.05M

19.77%-1.87M

30.16%-1.67M

6.88%-2.21M

23.77%-2.29M

14.32%-2.33M

26.90%-2.40M

31.20%-2.37M

3.65%-3.01M

19.12%-2.72M

-48.91%-3.28M

-61.29%-3.44M

-13.49%-3.12M

-115.53%-3.36M

-14.09%-2.20M

-3.59%-2.13M

4.11%-2.75M

---1.56M

---1.93M

---2.06M

---2.87M

淨非營業利息收入（費用）

股權收益

----

--0.00

-100.00%0.00

--0.00

--3.21M

--0.00

特殊收入（費用）

-148.74%-482.00K

15.01%3.19M

-73.49%1.77M

-110.29%-956.00K

114.09%989.00K

--2.77M

--6.67M

185980.00%9.29M

-23290.00%-7.02M

100.00%0.00

-100.00%0.00

97.02%-5.00K

---30.00K

---5.00K

--35.00K

---168.00K

-100.00%0.00

--0.00

--106.00K

--0.00

----

--0.00

100.00%0.00

--0.00

---800.00K

----

--0.00

-固定資產出售收益

----

--73.00K

----

--0.00

-100.00%0.00

----

--0.00

--1.75M

----

其他非經營性收入（費用）

27.66%60.00K

-332.56%-100.00K

-16.67%35.00K

855.56%68.00K

--47.00K

4200.00%43.00K

1300.00%42.00K

-325.00%-9.00K

----

-75.00%1.00K

50.00%3.00K

0.00%4.00K

103.57%3.00K

33.33%4.00K

-50.00%2.00K

0.00%4.00K

-119.22%-84.00K

-96.97%3.00K

--4.00K

300.00%4.00K

8640.00%437.00K

482.35%99.00K

-100.00%0.00

-99.61%1.00K

117.86%5.00K

-67.31%17.00K

318.18%48.00K

64.74%257.00K

-833.33%-28.00K

2700.00%52.00K

74.42%-22.00K

15700.00%156.00K

-102.36%-3.00K

---2.00K

---86.00K

---1.00K

--127.00K

稅前利潤

-42.91%-6.89M

-20.57%-3.32M

-432.25%-4.59M

-224.82%-6.46M

48.90%-4.82M

20.42%-2.75M

125.66%1.38M

293.24%5.18M

-187.28%-9.44M

-25.24%-3.46M

-121.22%-5.39M

-2.33%-2.68M

-21.35%-3.29M

-27.88%-2.76M

-24.60%-2.44M

-5.78%-2.62M

-35.83%-2.71M

10.41%-2.16M

22.54%-1.96M

-1.77%-2.48M

34.29%-1.99M

11.49%-2.41M

21.69%-2.52M

22.84%-2.43M

3.35%-3.03M

16.83%-2.72M

-47.51%-3.22M

-61.56%-3.15M

-877.57%-3.14M

-112.05%-3.27M

-8.65%-2.19M

-505.90%-1.95M

88.37%-321.00K

---1.54M

---2.01M

---322.00K

---2.76M

所得稅

--7.00K

--18.00K

----

100.00%0.00

----

-933.33%-150.00K

----

--18.00K

--54.00K

--3.00K

--73.00K

----

除稅後利潤

-43.05%-6.90M

-21.22%-3.34M

-432.25%-4.59M

-224.82%-6.46M

48.90%-4.82M

20.42%-2.75M

125.66%1.38M

293.24%5.18M

-187.28%-9.44M

-25.24%-3.46M

-121.22%-5.39M

-2.33%-2.68M

-21.35%-3.29M

-27.88%-2.76M

-24.60%-2.44M

-5.78%-2.62M

-35.83%-2.71M

4.47%-2.16M

22.54%-1.96M

-1.77%-2.48M

34.29%-1.99M

17.55%-2.26M

22.98%-2.52M

22.92%-2.43M

5.54%-3.03M

16.28%-2.74M

-49.98%-3.28M

-61.71%-3.15M

-900.31%-3.21M

-112.05%-3.27M

-8.65%-2.19M

-505.90%-1.95M

88.37%-321.00K

---1.54M

---2.01M

---322.00K

---2.76M

持續經營利潤

-43.05%-6.90M

-21.22%-3.34M

-432.25%-4.59M

-224.82%-6.46M

48.90%-4.82M

20.42%-2.75M

125.66%1.38M

293.24%5.18M

-187.28%-9.44M

-25.24%-3.46M

-121.22%-5.39M

-2.33%-2.68M

-21.35%-3.29M

-27.88%-2.76M

-24.60%-2.44M

-5.78%-2.62M

-35.83%-2.71M

4.47%-2.16M

22.54%-1.96M

-1.77%-2.48M

34.29%-1.99M

17.55%-2.26M

22.98%-2.52M

22.92%-2.43M

5.54%-3.03M

16.28%-2.74M

-49.98%-3.28M

-61.71%-3.15M

-900.31%-3.21M

-112.05%-3.27M

-8.65%-2.19M

-505.90%-1.95M

88.37%-321.00K

---1.54M

---2.01M

---322.00K

---2.76M

停止經營利潤

----

--0.00

100.00%0.00

37.66%-96.00K

---188.00K

---21.00K

---258.00K

---154.00K

----

歸屬少數股東的淨利潤

100.00%0.00

62.96%-10.00K

48.15%-14.00K

---9.00K

-500.00%-12.00K

-325.00%-27.00K

-170.00%-27.00K

----

96.55%-2.00K

1300.00%12.00K

---10.00K

-700.00%-8.00K

-5700.00%-58.00K

---1.00K

100.00%0.00

0.00%-1.00K

50.00%-1.00K

100.00%0.00

---1.00K

93.33%-2.00K

96.43%-2.00K

100.00%0.00

65.91%-30.00K

-64.71%-56.00K

-214.29%-66.00K

9.30%-78.00K

-137.84%-88.00K

40.35%-34.00K

-107.12%-21.00K

66.67%-86.00K

---37.00K

---57.00K

--295.00K

---258.00K

歸属于母公司的淨利潤

-44.09%-6.93M

-21.75%-3.34M

-425.18%-4.58M

-223.90%-6.45M

49.00%-4.81M

20.72%-2.74M

126.11%1.41M

294.98%5.20M

-187.98%-9.44M

-27.86%-3.46M

-121.81%-5.40M

-1.95%-2.67M

-21.10%-3.28M

-25.25%-2.70M

-24.55%-2.44M

-5.82%-2.62M

-29.60%-2.71M

11.77%-2.16M

23.12%-1.96M

8.00%-2.47M

34.48%-2.09M

9.77%-2.45M

21.05%-2.54M

12.95%-2.69M

-1.72%-3.19M

14.91%-2.71M

-49.74%-3.22M

-60.05%-3.09M

-1233.19%-3.13M

-111.41%-3.19M

-10.08%-2.15M

-212.80%-1.93M

90.61%-235.00K

---1.51M

---1.95M

---617.00K

---2.50M

優先股派息

--37.00K

----

歸屬普通股東的淨利潤

-44.09%-6.93M

-21.75%-3.34M

-425.18%-4.58M

-223.90%-6.45M

49.00%-4.81M

20.72%-2.74M

126.11%1.41M

294.98%5.20M

-187.98%-9.44M

-27.86%-3.46M

-121.81%-5.40M

-1.95%-2.67M

-21.10%-3.28M

-25.25%-2.70M

-24.55%-2.44M

-5.82%-2.62M

-29.60%-2.71M

11.77%-2.16M

23.12%-1.96M

8.00%-2.47M

34.48%-2.09M

9.77%-2.45M

21.05%-2.54M

12.95%-2.69M

-1.72%-3.19M

14.91%-2.71M

-49.74%-3.22M

-60.05%-3.09M

-1233.19%-3.13M

-111.41%-3.19M

-10.08%-2.15M

-212.80%-1.93M

90.61%-235.00K

---1.51M

---1.95M

---617.00K

---2.50M

基本每股收益

-16.69%-0.58

-4.05%-0.31

-378.39%-0.44

-205.45%-0.64

85.41%-0.49

90.62%-0.30

103.18%0.16

124.71%0.61

-11.38%-3.38

-27.88%-3.20

-121.79%-5.01

-1.93%-2.47

-21.07%-3.04

-25.23%-2.51

-24.53%-2.26

-5.80%-2.43

-28.88%-2.51

12.36%-2.00

23.65%-1.81

8.67%-2.29

34.62%-1.95

9.86%-2.28

21.13%-2.37

13.01%-2.51

2.34%-2.98

21.10%-2.53

-42.55%-3.01

-52.39%-2.89

-1221.32%-3.05

-116.95%-3.21

-10.07%-2.11

-212.83%-1.89

90.61%-0.23

---1.48

---1.92

---0.61

---2.46

稀釋每股收益

-16.69%-0.58

-4.05%-0.31

-438.14%-0.44

-205.45%-0.64

85.41%-0.49

90.62%-0.30

102.62%0.13

124.71%0.61

-11.38%-3.38

-27.88%-3.20

-121.79%-5.01

-1.93%-2.47

-21.07%-3.04

-25.23%-2.51

-24.53%-2.26

-5.80%-2.43

-28.88%-2.51

12.36%-2.00

23.65%-1.81

8.67%-2.29

34.62%-1.95

9.86%-2.28

21.13%-2.37

13.01%-2.51

2.34%-2.98

21.10%-2.53

-42.55%-3.01

-52.39%-2.89

-1221.32%-3.05

-116.95%-3.21

-10.07%-2.11

-212.83%-1.89

90.61%-0.23

---1.48

---1.92

---0.61

---2.46

每股派息

--0.00

----

--0.00

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Serina Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 SER 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Serina Therapeutics Inc 財年末的營收是多少？



Serina Therapeutics Inc 2025 財年營收為 130.00K，高於上一財年的 56.00K。

Serina Therapeutics Inc 全年的淨利潤是多少？



Serina Therapeutics Inc 2025 財年淨利潤為 -19.18M。

Serina Therapeutics Inc 上一季度的淨利潤是多少？



Serina Therapeutics Inc 最近一個季度的淨利潤為 -6.93M。

Serina Therapeutics Inc 年度營業利潤是多少？



Serina Therapeutics Inc 2025 財年的營業利潤為 -24.02M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。